comparemela.com
Home
Live Updates
First FcRn blocker approved in UK for myasthenia gravis : comparemela.com
First FcRn blocker approved in UK for myasthenia gravis
VYVGART (efgartigimod alfa-fcab) has been approved for adults with generalised myasthenia gravis by the UK's MHRA.
Related Keywords
United Kingdom ,
Saiju Jacob ,
University Hospitals Birmingham ,
Regulatory Agency ,
First Fcrn ,
United Kingdom Medicines ,
Professor Saiju Jacob ,
Consultant Neurologist ,
University Hospitals ,
Myasthenia Gravis Activities ,
Daily Living ,
Quantitative Myasthenia Gravis ,
Promising Innovative Medicine ,
Early Access ,
Medicines Scheme ,
comparemela.com © 2020. All Rights Reserved.